Report suggests broader GI role for fecal transplants

09/2/2013 | Vaccine News Daily

Fecal transplants, which are used to treat recurrent Clostridium difficile infection, could also benefit patients with other gastrointestinal diseases, such as constipation, irritable bowel syndrome and inflammatory bowel disease, according to a report from researchers at Montefiore Medical Center in New York. Researchers said long-term follow-up of one study showed C. diff patients had a 91% primary and 98% secondary cure rate with fecal microbiota transplantation.

View Full Article in:

Vaccine News Daily

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR